Zobrazeno 1 - 10
of 118
pro vyhledávání: '"T. C. Merigan"'
Autor:
M. Holodniy, D. A. Katzenstein, S. Sengupta, A. M. Wang, C. Casipit, D. H. Schwartz, M. Konrad, E. Groves, T. C. Merigan
Publikováno v:
Journal of Infectious Diseases. 190:2050-2054
Publikováno v:
The Journal of Immunology. 155:2232-2239
CTL activity is a major component of the host immune response associated with control of HIV replication in the course of infection. Emerging populations of HIV overcome the protective effector mechanisms with variant sequences unrecognized by CTL. T
Publikováno v:
The Journal of Immunology. 146:3578-3582
The antiviral activity of recombinant human macrophage CSF (M-CSF) against genital herpes simplex virus type-2 (HSV-2) infection in guinea pigs was investigated. M-CSF stimulates proliferation of human and guinea pig peripheral blood monocytes, speci
Publikováno v:
The Journal of Immunology. 144:1705-1710
Using flow cytometry technology and multiparameter analyses, we report early and characteristic alterations in lymphoid cell profile in spleen and lymph nodes due to LP-BM5 retrovirus disease (murine AIDS (MAIDS)) and the effect of azido dideoxythymi
Publikováno v:
Cell transplantation. 9(3)
Peripheral blood samples from HIV-seropositive individuals enrolled in a pilot clinical trial investigating the use of allogeneic dendritic cell therapy were evaluated for mixed chimerism. In this study, dendritic cells from HLA-identical, HIV-serone
Autor:
J D, Baxter, D L, Mayers, D N, Wentworth, J D, Neaton, M L, Hoover, M A, Winters, S B, Mannheimer, M A, Thompson, D I, Abrams, B J, Brizz, J P, Ioannidis, T C, Merigan
Publikováno v:
AIDS (London, England). 14(9)
To determine the short-term effects of using genotypic antiretroviral resistance testing (GART) with expert advice in the management of patients failing on a protease inhibitor and two nucleoside reverse transcriptase inhibitors.Prospective randomize
Autor:
M A, Winters, J D, Baxter, D L, Mayers, D N, Wentworth, M L, Hoover, J D, Neaton, T C, Merigan
Publikováno v:
Antiviral therapy. 5(1)
The frequency of protease and reverse transcriptase (RT) gene mutations was determined in HIV-1 strains from 153 patients entering the CPCRA 046 (GART) study who were failing triple-drug regimens consisting of one protease inhibitor (PI) and two RT i
Autor:
C M, Gray, J, Lawrence, J M, Schapiro, J D, Altman, M A, Winters, M, Crompton, M, Loi, S K, Kundu, M M, Davis, T C, Merigan
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 162(3)
Peptide/MHC tetrameric complexes were used to enumerate the frequency of HLA class I-restricted epitope-specific CD8+ T cells in 18 HLA-A*0201 HIV type 1-infected asymptomatic patients. HLA-A*0201 molecules were complexed to HIV Gag p17 (amino acids
Autor:
J P, Kleim, M, Winters, A, Dunkler, J R, Suarez, G, Riess, I, Winkler, J, Balzarini, D, Oette, T C, Merigan
Publikováno v:
The Journal of infectious diseases. 179(3)
The safety and antiviral activity of the second-generation nonnucleoside inhibitor HBY 097 was investigated in asymptomatic or mildly symptomatic human immunodeficiency virus (HIV)-1-infected patients in a randomized, double-blinded, dose-escalation